Cargando…
Polymorphisms in the RANK/RANKL Genes and Their Effect on Bone Specific Prognosis in Breast Cancer Patients
The receptor activator of NF-κB (RANK) pathway is involved in bone health as well as breast cancer (BC) pathogenesis and progression. Whereas the therapeutic implication of this pathway is established for the treatment of osteoporosis and bone metastases, the application in adjuvant BC is currently...
Autores principales: | Hein, Alexander, Bayer, Christian M., Schrauder, Michael G., Häberle, Lothar, Heusinger, Katharina, Strick, Reiner, Ruebner, Matthias, Lux, Michael P., Renner, Stefan P., Schulz-Wendtland, Rüdiger, Ekici, Arif B., Hartmann, Arndt, Beckmann, Matthias W., Fasching, Peter A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3963378/ https://www.ncbi.nlm.nih.gov/pubmed/24729980 http://dx.doi.org/10.1155/2014/842452 |
Ejemplares similares
-
Endometriosis as a risk factor for ovarian or endometrial cancer — results of a hospital-based case–control study
por: Burghaus, Stefanie, et al.
Publicado: (2015) -
RANKL and OPG and their influence on breast volume changes during pregnancy in healthy women
por: Wunderle, Marius, et al.
Publicado: (2020) -
HLA-G and HLA-F protein isoform expression in breast cancer patients receiving neoadjuvant treatment
por: Wuerfel, Franziska M., et al.
Publicado: (2020) -
Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatment
por: Fasching, Peter A, et al.
Publicado: (2011) -
Cost effectiveness of bilateral risk-reducing mastectomy and salpingo-oophorectomy
por: Schrauder, Michael G., et al.
Publicado: (2019)